The British pharmaceutical giant is working with the U.K. Dementia Research Institute to exploit a “natural randomization” ...

GSK said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its ...

After multiple studies have suggested a link between its shingles vaccine and dementia prevention, GSK is taking advantage of ...

Getting the Shingrix vaccine after the age of 50 can reduce your chances of developing the painful skin condition known as ...

The recombinant zoster vaccine is effective in preventing herpes zoster in adults aged 50 years or older with rheumatoid ...

The study will analyse electronic health records of 65- and 66-year olds from the UK’s National Health Service (NHS).

GSK is enlisting the aid of China’s Chongqing Zhifei Biological Products (Zhifei) to drive sales of its most important vaccine, Shingrix, in China over the next few years, and may also call upon ...

If the vaccine works and is developed as rapidly as Pfizer and BioNTech hope, it could spell trouble for GSK, which is depending on Shingrix to drive revenues as it works towards rolling out a ...

Mar. 12, 2025 — Researchers helped conduct an important new global health study that found a vaccine that protects against five strains of meningitis prevalent in sub-Saharan Africa is safe and ...